Silo Pharma's ketamine implant for fibromyalgia shows promis

Silo Pharma’s dissolvable ketamine implant, initially targeting fibromyalgia and chronic pain, has seen success in early research.

Related Keywords

Eric Weisblum , , Bio Developments , Markets Amp Regulations , Pipelines , Emerging Markets , Ketamine , Fibromyalgia , Chronic Pain , Sychedelic , Research ,